Skip to content

Medpace

US · MEDP #1015 by market cap Listed 2016
610.54 -23.44 -3.70%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Recent news

  • Rating change
    Mizuho Securities Maintains Medpace(MEDP.US) With Buy Rating, Raises Target Price to $700
    Market Newswire · 2026/10/7
  • Rating change
    Baird Downgrades Medpace(MEDP.US) to Hold Rating, Raises Target Price to $547
    Market Newswire · 2026/7/8
  • Rating change
    Mizuho Securities Maintains Medpace(MEDP.US) With Buy Rating, Maintains Target Price $665
    Market Newswire · 2026/7/29
  • Rating change
    A Quick Look at Today's Ratings for Medpace(MEDP.US), With a Forecast Between $400 to $477
    Market Newswire · 2026/4/25
  • Rating change
    UBS Maintains Medpace(MEDP.US) With Hold Rating, Maintains Target Price $673
    Market Newswire · 2026/10/3
  • Form 144 | Medpace(MEDP.US) Officer Proposes to Sell 10.87 Million in Common Stocks
    Market Newswire · 2026/10/27
  • A Quick Look at Today's Ratings for Medpace(MEDP.US), With a Forecast Between $675 to $730
    Market Newswire · 2026/10/23
  • Rating change
    A Quick Look at Today's Ratings for Medpace(MEDP.US), With a Forecast Between $535 to $692
    Market Newswire · 2026/7/24
  • Rating change
    Barclays Maintains Medpace(MEDP.US) With Hold Rating, Raises Target Price to $625
    Market Newswire · 2026/10/7
  • Rating change
    Jefferies Maintains Medpace(MEDP.US) With Buy Rating, Cuts Target Price to $490
    Market Newswire · 2026/6/15
  • Rating change
    UBS Initiates Medpace(MEDP.US) With Hold Rating, Announces Target Price $673
    Market Newswire · 2026/9/30
  • Rating change
    Mizuho Securities Maintains Medpace(MEDP.US) With Buy Rating, Raises Target Price to $665
    Market Newswire · 2026/7/25
  • Rating change
    Mizuho Securities Maintains Medpace(MEDP.US) With Buy Rating, Raises Target Price to $586
    Market Newswire · 2026/7/13
  • A Quick Look at Today's Ratings for Medpace(MEDP.US), With a Forecast Between $673 to $730
    Market Newswire · 2026/10/24
  • Rating change
    William Blair Initiates Medpace(MEDP.US) With Hold Rating
    Market Newswire · 2026/7/23
  • Medpace(MEDP.US) Officer Sells US$13.54 Million in Common Stock
    Market Newswire · 2026/10/29
  • Rating change
    RBC Capital Maintains Medpace(MEDP.US) With Buy Rating, Maintains Target Price $692
    Market Newswire · 2026/10/7
  • Rating change
    Truist Financial Maintains Medpace(MEDP.US) With Hold Rating
    Market Newswire · 2026/9/17
  • BMO Capital Maintains Medpace(MEDP.US) With Hold Rating, Raises Target Price to $670
    Market Newswire · 2026/10/26
  • Rating change
    Truist Financial Maintains Medpace(MEDP.US) With Hold Rating, Maintains Target Price $609
    Market Newswire · 2026/7/29
  • GUIDANCE: (MEDP) Medpace Expects Full Year 2026 Revenue Range $2.84B - $2.86B, Vs. FactSet Est of $2.85B
    MT Newswires · 2026/10/22
  • Earnings Flash (MEDP) Medpace Posts Q3 EPS $4.84, Vs. FactSet Est of $4.44
    MT Newswires · 2026/10/22
  • Rating change
    William Blair Maintains Medpace(MEDP.US) With Hold Rating
    Market Newswire · 2026/4/23
  • Rating change
    RBC Capital Initiates Medpace(MEDP.US) With Buy Rating, Announces Target Price $522
    Market Newswire · 2026/3/3
  • Rating change
    Jefferies Maintains Medpace(MEDP.US) With Buy Rating, Raises Target Price to $560
    Market Newswire · 2026/2/13

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Medpace discussion 0 comments

Add a comment